Una Health Secures Seven-Figure Funding from IBB and the EU to Advance AI-Driven Metabolic Health Solutions
Una Health, a leading metabolic health company leader in digital health innovation, proudly announces a major funding boost from Investitionsbank Berlin (IBB) and the European Union. This substantial funding will propel the development of "Una A.I.," a novel artificial intelligence system designed to provide personalized support for individuals with metabolic disorders.
Addressing the Growing Challenge of Metabolic Health
Metabolic health issues, such as diabetes, obesity, and cardiovascular disease, are affecting hundreds of millions globally. Una A.I. seeks to tackle these conditions with a highly individualized approach, delving into each person's unique metabolic makeup to provide tailored lifestyle and health recommendations. By focusing on personalized insights, Una A.I. empowers healthcare professionals and individuals to understand and manage metabolic health effectively.
Enabling Precision Care through Cutting-Edge Technology
Una A.I. uses digital twin technology to model each person’s unique metabolic and behavioral profile, creating a Digital Metabolic Twin and a Digital Behavioral Twin. By integrating these digital twins, Una A.I. offers a new level of insight into the complex interplay of biological and lifestyle factors that impact metabolic health and the role of existing therapies, from oral medications to GLP-1 receptor agonists. This combination enables Una A.I. to deliver more precise, individualized health recommendations, fostering sustainable lifestyle changes and early intervention opportunities.
Pioneering New Possibilities in Metabolic Health Research
With this funding, Una Health is driven to enable a deeper exploration of metabolic dysfunction, allowing for more precise, individualized approaches to both treatment and research. By analyzing extensive data patterns, Una Health aims to unlock new paths toward early diagnosis and customized therapies, ultimately enhancing the quality of life for those affected by metabolic disorders. "This funding highlights the potential of Una A.I. to transform the landscape of metabolic health," says Pascal Grimm, CEO of Una Health. "With the support of IBB and the EU, we are poised to advance how we approach metabolic health, enabling data-driven and scalable decision-making to address each individual’s unique needs."
Accelerating Development to Bring Innovation to Market
The new funding will expedite Una Health's research and development efforts, bringing Una A.I. closer to the millions who could benefit from its personalized support for metabolic health. By doubling down on Una Health's expertise with cutting-edge and human-centered health technology, the company is committed to creating a healthier, more proactive future for individuals living with metabolic conditions.
About Una Health
Based in Germany, Una Health specializes in digital health solutions tailored for Type 2 diabetes and metabolic health. The Una Health platform combines biodata with lifestyle coaching to empower individuals to take control of their health, adapt their lifestyles, and cultivate lasting healthy habits. With a commitment to individual empowerment, Una Health merges technology with medical expertise to make personalized health accessible to all.
For more information, please visit www.unahealth.de.
